You are not logged in.
Login to update your contact information or edit your email preferences, or Register to create an account.
allows the use, on a case-by-case basis, of an investigational drug outside of
a clinical trial to treat a patient with a serious or immediately
life-threatening disease or condition who has no comparable or satisfactory
alternative treatment options. However, FDA often denies this access. A new
bill, to be introduced shortly, would change FDA’s “compassionate use” rule so
that individuals who have exhausted all conventional cancer treatments can have
all of their treatment choices honored without need to obtain federal
government approval—essentially removing FDA from the process.
A briefing and a
screening of the documentary Cut Poison
Burn will be held so that members of Congress and their staff can learn
about the soon-to-be-introduced Freedom of Choice Bill. Under it, any patient
diagnosed with a terminal illness, for whom a physician determines FDA approved
drugs are likely not curative, may obtain access to any experimental drug upon
execution of an informed consent without need for FDA approval.
Please ask your
representative to attend the briefing and screening, and ask him or her to
cosponsor the Freedom of Choice Bill when it is introduced.
Please personalize your message if you have the time!
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]